TCF7L2 rs12255374: What Your Genotype Means
The rs12255374 variant is a single nucleotide polymorphism located within the TCF7L2 gene. Research into its potential association with polycystic ovary syndrome (PCOS) has yielded mixed results, reflecting the complex genetic landscape of reproductive and metabolic health.
What each genotype means
Typical metabolic risk profile
You carry two copies of the common G allele at rs12255372 in the TCF7L2 gene. In metabolic and reproductive research, this baseline genotype is not associated with the increased susceptibility to polycystic ovary syndrome (PCOS) or impaired glucose signaling linked to the alternative allele. Overall evidence connecting this specific locus to hyperandrogenism remains limited and varies across different ancestral backgrounds.
Carried by approximately 50% to 55% of individuals of European ancestry and more than 90% of individuals of East Asian ancestry.
Moderately elevated metabolic risk
You carry one copy of the T variant allele at rs12255372 in TCF7L2. Some candidate gene studies report a modest association between the heterozygous genotype and altered metabolic signaling or polycystic ovary syndrome (PCOS) susceptibility, largely through pathways regulating insulin and glucose handling. However, the overall clinical evidence remains limited, and associations vary widely across distinct ethnic populations.
Carried by approximately 35% to 40% of individuals of European descent and under 10% in East Asian populations.
Elevated metabolic risk
You carry two copies of the T risk allele at rs12255372 in TCF7L2. Research shows an additive gene-dosage effect where carrying two T alleles is associated with the highest relative statistical risk for metabolic dysregulation and potential predisposition to hyperandrogenic traits and PCOS. Because research into reproductive outcomes shows mixed replication and limited direct evidence across diverse groups, this genetic marker alone does not diagnose any condition.
Carried by approximately 5% to 10% of individuals of European ancestry, but is very rare in East Asian populations.
Understanding the rs12255374 Variant
The rs12255374 variant is a specific change in the DNA sequence located within the TCF7L2 gene. In genomics, a single nucleotide polymorphism (SNP) like rs12255374 represents a position where one of the four DNA building blocks—adenine, thymine, cytosine, or guanine—differs between individuals. This particular variant is often studied alongside other nearby markers in the TCF7L2 region, which is well-known for its strong influence on glucose metabolism and type 2 diabetes risk. Because these variants are often inherited together in blocks, researchers frequently analyze them to understand how they might influence various physiological processes. While the physical location of this SNP is well-mapped on the human genome, its functional impact on the protein produced by the TCF7L2 gene remains a subject of ongoing investigation in the scientific community.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for making a protein that acts as a transcription factor. Transcription factors are proteins that bind to specific regions of DNA to help control the activity of other genes. TCF7L2 is a key component of the Wnt signaling pathway, which is essential for many biological processes, including cell growth, differentiation, and the development of various tissues. In the context of metabolism, TCF7L2 is highly active in the pancreas, where it plays a critical role in regulating insulin secretion and glucose homeostasis. Because of its central role in these pathways, variations in this gene have been extensively studied to see if they contribute to conditions characterized by metabolic dysfunction, such as insulin resistance, which is a common feature observed in many individuals diagnosed with polycystic ovary syndrome (PCOS).
Research and Evidence Strength
The evidence linking rs12255374 and related TCF7L2 variants to PCOS is currently considered limited and inconsistent. Some studies have reported a statistical association between specific TCF7L2 variants and an increased susceptibility to PCOS, suggesting a potential genetic link between metabolic pathways and reproductive health. However, other large-scale studies have failed to replicate these findings, finding no significant relationship between these specific SNPs and the development of PCOS or related androgen levels. This discrepancy highlights the complexity of PCOS, which is a multifactorial condition influenced by a combination of genetic, environmental, and lifestyle factors. Because the results across different populations and study designs are mixed, the scientific community has not reached a consensus on whether this specific variant serves as a reliable predictor for PCOS risk.
Population Frequency and Interpretation
The frequency of the rs12255374 variant varies significantly across different ancestral populations. In many groups, the variant is common, meaning a large portion of the population carries at least one copy of the minor allele. Because it is a common variant, it is important to interpret any individual genotype result with caution. Having a particular genotype does not mean an individual will develop a specific condition, nor does it guarantee protection against one. Genetic associations are based on statistical trends observed in large groups of people, not on individual diagnostic certainty. If you are concerned about your reproductive or metabolic health, it is essential to consult with a qualified healthcare provider. They can evaluate your personal and family medical history, perform necessary clinical tests, and provide guidance tailored to your specific health needs.
How common is this variant?
The rs12255374 variant is common across many global populations, though the specific frequency of the G and T alleles differs significantly depending on ancestral background.
Frequently asked questions
Does having the rs12255374 variant mean I have PCOS?
No. Genetic variants are only one of many factors that contribute to health conditions. A diagnosis of PCOS is based on clinical criteria, such as hormone levels and physical symptoms, not on a single genetic test result.
Is TCF7L2 related to diabetes?
Yes, TCF7L2 is widely recognized as one of the strongest genetic risk factors for type 2 diabetes. Variants in this gene are known to influence insulin secretion and glucose regulation.
Should I get tested for this variant?
Genetic testing for this specific variant is not currently recommended for routine clinical diagnosis of PCOS. If you have concerns about your health, speak with a doctor who can order appropriate diagnostic tests.
Can I change my risk if I have a 'higher-attention' genotype?
Genetic risk is fixed, but lifestyle factors like diet, exercise, and weight management play a major role in metabolic health. Discussing your overall health profile with a clinician is the best way to manage your risk factors.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12255374?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.